Kineta, Inc. Files 8-K on Shareholder Votes and Financials

Kineta, Inc./De 8-K Filing Summary
FieldDetail
CompanyKineta, Inc./De
Form Type8-K
Filed DateJun 24, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-action, financial-reporting

TL;DR

Kineta filed an 8-K on June 24th covering shareholder votes and financials from June 23rd.

AI Summary

Kineta, Inc. filed an 8-K on June 24, 2025, reporting on matters submitted to a vote of security holders, Regulation FD disclosures, and financial statements. The filing pertains to events that occurred on June 23, 2025. Kineta, Inc., formerly known as Yumanity Therapeutics, Inc., is a pharmaceutical preparations company incorporated in Delaware.

Why It Matters

This 8-K filing provides updates on important corporate actions and financial reporting for Kineta, Inc., which can influence investor decisions and market perception.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of corporate events and financial information, not indicating immediate operational or financial distress.

Key Numbers

  • 001-37695 — SEC File Number (Identifies Kineta, Inc. in SEC filings)
  • 20-8436652 — IRS Employer Identification No. (Tax identification for Kineta, Inc.)

Key Players & Entities

  • Kineta, Inc. (company) — Registrant
  • Yumanity Therapeutics, Inc. (company) — Former Company Name
  • 20250623 (date) — Earliest event reported
  • 20250624 (date) — Filing Date

FAQ

What specific matters were submitted to a vote of security holders?

The filing indicates 'Submission of Matters to a Vote of Security Holders' as an item, but the specific details of these matters are not provided in the excerpt.

What is the significance of the Regulation FD Disclosure item?

Regulation FD (Fair Disclosure) ensures that material non-public information is disclosed to all investors simultaneously, so this item suggests such disclosures were made.

When was Kineta, Inc. formerly known as Yumanity Therapeutics, Inc.?

The date of the name change from Yumanity Therapeutics, Inc. to Kineta, Inc. was December 23, 2020.

What is Kineta, Inc.'s Standard Industrial Classification (SIC) code and industry?

Kineta, Inc. has a SIC code of 2834, which corresponds to Pharmaceutical Preparations.

Where is Kineta, Inc. headquartered?

Kineta, Inc.'s business and mailing address is 7683 SE 27th Street, Suite 481, Mercer Island, WA 98040.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 24, 2025 regarding KINETA, INC./DE.

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.